FIELD: biotechnology.
SUBSTANCE: present invention relates to a stable nucleic acid composition.
EFFECT: invention enables stable preservation of nucleic acid as an active ingredient in the form of a solution in the pH range from 4 to 11 at ambient temperature for a long period of time.
15 cl, 16 tbl, 7 ex, 23 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION, IN STABLE CONDITION, SINGLE-STRANDED NUCLEIC ACID MOLECULE WHICH SUPPRESSES EXPRESSION OF GENE TGF-Β1 | 2016 |
|
RU2714257C2 |
| SINGLE-CHEMICAL NUCLEIC ACID MOLECULES FOR GENE EXPRESSION CONTROL | 2011 |
|
RU2628311C2 |
| SINGLE-STRANDED NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF PRORENIN GENE OR PRORENIN RECEPTOR GENE, AND USE THEREOF | 2016 |
|
RU2718984C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
| EMULSIONS OF “OIL-IN-WATER” TYPE, WHICH CONTAIN NUCLEIC ACIDS | 2012 |
|
RU2606846C2 |
| STABLE COMPOSITIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN AND THEIR USE | 2014 |
|
RU2773172C2 |
| METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
| COMPOSITIONS BASED ON BISPECIFIC ANTIBODIES TO IL-4/IL-13 | 2014 |
|
RU2690850C2 |
| DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2737264C2 |
